Frontier Medicines

Frontier is a precision medicine company that has cutting-edge platform designed to generate medicines against previously undruggable disease-causing proteins.

[Sally Church @MaverickNY]

A couple of important gems from the (over-crowded) poster halls really stood out for me this year at #AACR24.
Will have some important clinical implications should the concept hold up in patients:
https://t.co/pZUzQBnIl8

[Frontier Medicines @FrontierMeds]

The Frontier Medicines team wishes everyone in the U.S. a happy and healthy #July4th!

[Frontier Medicines @FrontierMeds]

Our science never stops, but today our offices are closed, as we recognize the importance of #Juneteenth.
#listeningandlearning

[Frontier Medicines @FrontierMeds]

Are you at #BIO2023? Will the IPO market return? Join our CEO, Chris Varma, and leading experts in the field, as they discuss the current biotech financial climate. This afternoon at 2:15 p.m. ET Room 210A #standupforscience

[Frontier Medicines @FrontierMeds]

This month, and every month, we honor and celebrate the LGBTQIA+ community. #PrideMonth #Pride2023

[Frontier Medicines @FrontierMeds]

We are thrilled to welcome Dr. Andrew Krivoshik as CMO. He has advanced multiple groundbreaking medicines, and we’re excited to have him join Frontier as we prepare to move FMC-376 into the clinic. Read more here https://t.co/lYy4idmAES #biotech, #chemoproteomics

[Frontier Medicines @FrontierMeds]

Decades after the human genome project, only 15% of the human proteome has approved treatments. We’re opening up new Frontiers in what is possible. Learn more here: https://t.co/SiRGgNuoDs #DNADay #DNADay23 #biotech #chemoproteomics

[Frontier Medicines @FrontierMeds]

Today at #AACR23, we’re talking about the Frontier™ platform, which gives us the tools to open new frontiers in drugging the undruggable. Visit poster 5333 (Section 30, Board 15). Learn more here: https://t.co/SiRGgNtQNU

[Frontier Medicines @FrontierMeds]

Thanks @MaverickNY, we’re feeling the AACR sunshine here at Frontier.

[Sally Church @MaverickNY]

Our latest #AACR23 post explores a couple of unexpected developments in the KRAS niche, which may surprise a few folks: https://t.co/IQWgC7WiVe

[Frontier Medicines @FrontierMeds]

We’re excited to unveil new preclinical data on our lead candidate, FMC-376, at #AACR23

More here: https://t.co/ajuP0ERihP

[Frontier Medicines @FrontierMeds]

We are excited to join the oncology community this week at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #cancer

[Frontier Medicines @FrontierMeds]

We are excited to join our colleagues in #biotech at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #oncology #chemoproteomics #undruggable
https://t.co/cs5HM3YBFx

[Frontier Medicines @FrontierMeds]

Please join us in welcoming Christo as Frontier’s SVP and Head of Business Development! His global pharma background coupled with his leadership experience in growing biotechs will be invaluable as we continue on our rapid trajectory. https://t.co/BST7llXz7t
#biotech

[Frontier Medicines @FrontierMeds]

At 12, Kyle knew she wanted to be a scientist. Now, she is helping to discover new breakthroughs for patients. We are proud to support scientists, especially the #WomeninScience here at Frontier. Tomorrow is International Day of Women & Girls in Science! #February11 #Biotech

[Frontier Medicines @FrontierMeds]

Kainat vividly recalls being the only girl at 4th grade math camp and advanced computing classes. Luckily for our Frontier™ Platform team, that only fueled her passion for STEM. This #February11, we applaud Kainat and all the #WomeninScience at Frontier and everywhere. #Biotech

[Frontier Medicines @FrontierMeds]

Our executive team is hosting meetings at the SVB Global Biopharma Conference. We hope to (virtually) see you there!

[Frontier Medicines @FrontierMeds]

Thanks @ldtimmerman for braving the floods and the hail to speak with our CEO, Chris Varma. The things we do for science! #JPM23

[Luke Timmerman @ldtimmerman]

Sometimes at #JPM23, you show up for a meeting soaking wet. With Chris Varma of Frontier Medicines.

[Frontier Medicines @FrontierMeds]

We’re excited to finally reconvene in person for this week’s 41st Annual @jpmorgan Health Care Conference. If you are here, please join our CEO, Chris Varma, for his presentation.
January 11, 2023, 10:00 a.m. PST
#JPM23 #Biotech

[Frontier Medicines @FrontierMeds]

We are excited to welcome Dr. Pamela Klein to our board of directors. Dr. Klein is a medical oncologist and senior biotechnology executive with over 20 years of experience who has advanced important cancer therapies to patients. #boardofdirectors